Pfizer says money killed AZ deal

Share this article:

Pfizer Chief Financial Officer Frank D'Amelio told an audience at a Goldman Sachs investment conference that the AstraZeneca deal fell apart over money, Bloomberg reports.

AstraZeneca turned down the $117 billion bid Memorial Day weekend, and Pfizer cannot approach the company until three months have lapsed.

Bloomberg reported earlier that perceived personal affronts also doomed Pfizer's overture.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters